Inventor
Xing Dai
Inventor
Cranford, NJ, US
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes21%
Y02ATechnologies for adaptation to climate change6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds2%
PatentTitleYear
10,689,401C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use202010,647,724Selective estrogen receptor degraders and uses thereof202010,604,534C5-C6-oxacyclic fused iminothiadiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use202010,047,098C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use20189,809,568'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,745,324'Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use'20179,718,818'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,688,654'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20179,573,939'Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases'20179,549,917'Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases'20179,549,921'Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C'20179,493,461'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C'20169,440,952'Compounds inhibiting leucine-rich repeat kinase enzyme activity'20169,364,482'Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases'20169,265,773'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases'20169,242,998'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C'20169,243,002'Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C'20169,006,228'Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment'20158,633,231'Substituted imidazolones, compositions containing such compounds and methods of use'20148,361,959'Spiro-imidazolone derivatives as glucagon receptor antagonists'20134,678,847'Process for preparing a terpolymer of tetrafluoroethylene, ethylene and a third monomer'1987Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1987Based in Shanghai, CN· patent location history
2013–2020Patents assigned to MERCK SHARP & DOHME (19)· patent assignee history
2013–2020Patents assigned to DAI XING (10)· patent assignee history
2013–2018Based in Cranford, NJ, US· patent location history
2016–2017Patents assigned to HE SHUWEN (5)· patent assignee history
2016–2017Patents assigned to LI PENG (5)· patent assignee history
2016–2017Patents assigned to MCCOMAS CASEY C (5)· patent assignee history
2020Based in Short Hills, NJ, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 19 | 2013–2020 |
| DAI XINGself | 10 | 2013–2020 |
| HE SHUWEN | 5 | 2016–2017 |
| LI PENG | 5 | 2016–2017 |
| MCCOMAS CASEY C | 5 | 2016–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cranford, New Jersey, US | 17 | 2013–2018 |
| Short Hills, New Jersey, US | 3 | 2020 |
| Shanghai, CN | 1 | 1987 |